Position in TERN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
3 quarters on record
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Derivatives in TERN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
27,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Trading LLC holds $28,211,005 across 28 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,407 | $7,112,720 | |
| 2 | MRNA |
Moderna, Inc.
|
101,066 | $7,077,651 | |
| 3 | BNTX |
BioNTech SE
|
25,690 | $2,390,454 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,037 | $1,817,318 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
33,938 | $1,323,921 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
19,679 | $1,081,164 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
18,595 | $1,014,171 | |
| 8 | ABVX |
Abivax S.A.
|
6,790 | $904,835 |
All Filings in TERN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 27,000 | Call | Sole | 2026-05-11 | |
| 2024-06-30 | — | 15,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 15,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||